Table 2. Survival analysis according to CIP2A immunoreactivity in subgroups of tongue cancer.
Low CIP2A expression
|
High CIP2A expression
|
||||
---|---|---|---|---|---|
Characteristic | 5-year survival | 95% CI | 5-year survival | 95% CI | P-valuea |
Age, years | |||||
<60 | 84.2 | 67.8–100.1 | 58.8 | 35.4–82.2 | 0.042 |
⩾60 | 65.0 | 44.1–85.9 | 60.0 | 35.2–84.8 | 0.347 |
Tumour size, mm | |||||
pT1 (⩽20) | 76.7 | 61.5–91.8 | 66.7 | 47.8–85.5 | 0.124 |
pT2 (21–40) | 66.7 | 35.9–97.5 | 28.6 | 0–62.0 | 0.018 |
Abbreviations: CIP2A=cancerous inhibitor of PP2A; CI=confidence interval.
Logrank test.